Tag - medicine

 
 

MEDICINE

Japan Times
ASIA PACIFIC
Apr 23, 2022
Questions over effectiveness of COVID remedy costs top Chinese scientist $2 billion
Debate over the efficacy of traditional Chinese medicine has intensified in recent weeks as the nation fights its worst outbreak since the early days of the pandemic.
Japan Times
BUSINESS / Companies
Apr 22, 2022
U.S. in talks with Japan's Shionogi to buy new COVID-19 pill
Shionogi's treatment is in late-stage clinical trials and hasn't yet been authorized, but in earlier studies, it reduced viral loads in patients within the first few days of use.
Japan Times
WORLD / Science & Health
Apr 18, 2022
Is COVID more dangerous than driving? How scientists are parsing COVID-19 risks.
Even two years into the pandemic, the coronavirus remains new enough, and its long-term effects unpredictable enough, that measuring the threat posed by an infection is a thorny problem.
Japan Times
WORLD / Science & Health
Apr 12, 2022
India hopes ‘Pharma City’ will break China’s grip on industry
It's a vast project that shows how governments are growing increasingly concerned about China's stranglehold over drug supplies — as well as the challenges they face in loosening it.
Japan Times
COMMENTARY / World
Apr 11, 2022
We need better COVID-19 booster shots, not more of the same
There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.
Japan Times
ASIA PACIFIC
Apr 10, 2022
With a $2.1 million cure their only hope, Indian parents plead for help online
India makes many of the world's drugs, but treatments for rare diseases like spinal muscular atrophy are imported and prohibitively costly.
Japan Times
BUSINESS
Apr 9, 2022
Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Japan Times
BUSINESS / Companies
Mar 28, 2022
Activist fund executives on board bolstered Olympus, CEO says
Olympus's shares have more than doubled since ValueAct, a U.S. hedge fund, persuaded Olympus to accept its director nominations in 2019.
Japan Times
WORLD / Science & Health
Mar 27, 2022
Second vaccine booster significantly lowers COVID-19 death rate: Israeli study
Senior citizens who received a second booster of the Pfizer-BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only.
Japan Times
LIFE / Lifestyle
Mar 27, 2022
How long should it take to grieve? Psychiatry has come up with an answer.
Will categorizing prolonged grief as a mental disorder help people in need get access to crucial treatment or hurt those who simply take longer to overcome loss?
Japan Times
WORLD / Science & Health / FOCUS
Mar 25, 2022
Drugmakers and scientists begin the hunt for long COVID treatments
Leading drugmakers, including those who have launched pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease.
Japan Times
JAPAN / FOCUS
Mar 15, 2022
Japanese firms near domestic rollout of their COVID-19 vaccines
Several companies are expecting to introduce their shots in the coming fiscal year, a major step in Japan reducing its reliance on foreign vaccine manufacturers.
Japan Times
BUSINESS
Mar 15, 2022
Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia's invasion of Ukraine and the needs of sick patients.
Japan Times
ASIA PACIFIC
Mar 13, 2022
China fires mayors and closes schools as COVID-19 outbreak spreads
China's National Health Commission announced Saturday that another 1,524 locally transmitted coronavirus cases had been detected in provinces across mainland China.
Japan Times
JAPAN
Mar 11, 2022
Fujifilm to halt enrollment in Avigan trial for COVID-19
The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.
Japan Times
WORLD / Science & Health
Mar 10, 2022
U.S. man with transplanted genetically modified pig heart dies
The patient, David Bennett, 'wasn't able to overcome what turned out to be the devastating debilitation' caused by the heart failure he experienced before the transplant.
Japan Times
WORLD / Science & Health
Mar 10, 2022
The humble cough drop could be used to map omicron’s spread
Soaring sales of lozenges, gargles and other over-the-counter medication has squeezed supplies — even in countries where cases are falling.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?